News Archives - Page 2 of 10 - Buhlmann Diagnostics Corp

Category: News

Visit BUHLMANN at DDW 2024

Assay Offerings Assay Offerings: We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap; FDA exempt BÜHLMANN fPELA® turbo (Pancreatic Elastase); Tests
Continue Reading

Visit BUHLMANN at AACC 2023 (Live)

Book a Meeting AACC 2023 Assays Offerings Assays Offerings: BUHLMANN Diagnostic Corp (BDC), offers the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap;
Continue Reading

Visit BUHLMANN @ AMLI 2023 (LIVE)

AMLI 2023 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications. Visit www.buhlmannlabs.com or email info@buhlmannlabs.com for more information.   AMLI 2023 36th AMLI Annual Meeting Aug 11-14,
Continue Reading

Visit BUHLMANN at DDW 2023

Assays Offerings Assays Offerings: We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap; FDA exempt BÜHLMANN fPELA® turbo (Pancreatic Elastase); Tests
Continue Reading

Visit BUHLMANN at ASCP 2022 (Live)

Assays Offerings BUHLMANN Diagnostic Corp, offers the broadest fecal calprotectin (fCAL) product range in the industry. These include FDA cleared calprotectin turbidimetric assay (fCAL® turbo k190784), pancreatic elastase turbidimetric assay (fPELA® turbo, Exempt) and a complimentary FDA cleared fecal extraction device (CALEX Cap®, k191718) which can easily extract both biomarkers and can be automated on
Continue Reading

Visit BUHLMANN at AACC 2022 (Live)

Assays Offerings Assays Offerings: BUHLMANN Diagnostic Corp (BDC), offers the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap; FDA exempt BÜHLMANN fPELA® turbo
Continue Reading

Visit BUHLMANN at DDW 2022

Assays Offerings Assays Offerings: We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap; FDA exempt BÜHLMANN fPELA® turbo (Pancreatic Elastase); Tests
Continue Reading

Buhlmann – Next Generation Food Allergy Drug Development Summit

Next Generation Food Allergy Drug Development Summit, July 20-22, 2021: BUHLMANN is proud to partner with this event, specifically focused on enhancing the food allergy drug development approach. Flow CAST® is the standardized, proven & assessable Basophil Activation Test. An accurate biomarker of an allergic reaction… in a vial. BUHLMANN Allergy Assay Offering Diagnosis of
Continue Reading

BUHLMANN Diagnostic Corp – New Partner Channel Agreement with Roche Diagnostics

BUHLMANN Diagnostic Corp – New Partner Channel Agreement with Roche Diagnostics.

Continue Reading

Educational Webinar recording from AMLI presentation by Dr Arne Roseth

BÜHLMANN fCAL® ELISA is FDA 510(k) cleared.  For in vitro Diagnostic Use. Health Canada License: 80726 Abstract Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease of the gut, which presents with periods of inflammatory activity (flares) and quiescent phases (remission) as can be seen in many chronic diseases. IBD includes several different diseases; the two most important
Continue Reading